PATENT CLAIM ANALYSIS

Application Number: 15926657
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "275000"]

Abstract:
A method of preventing or inhibiting L-cystine crystallization is disclosed, using the compounds of formula I: R 1a —[O] v -(-A-L-) m -A-[O] v —R 1b  wherein A, L, R 1a , R 1b , m, and v are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of conditions that are causally related to L-cystine crystallization, such as comprising (but not limited to) kidney stones.

Claim (Index 99):
A method for reducing a L-cystine crystal concentration in a human or animal comprising administering to a human or animal a pharmaceutically effective amount of a compound as defined in any of  claims 1 - 92 .

Metadata:
- Claim Count in Document: 307.0
- Percentile: 90.0
- Lexical Diversity: 1.56452
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13491816', '13902114', '12953096', '13989973', '14343410']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7822433556249372
- 35 USC 102 Novelty (BERT): 0.5858565894207564
- Combined Prediction Score: 0.7626046790045191
- Mean Citation Score: 371.147288
- Max Citation Score: 496.9118
- Similarity Product: 445.6833320542455

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test